Swindells S, Andrade-Villanueva JF, Richmond GJ, et al. Long-acting cabotegravir + rilpivirine as maintenance therapy: ATLAS week 48 results. CROI 2019, abstract 139.
BCG-hervaccinatie beschermt niet tegen persisterende M. tuberculosis-infectie
sep 2025 | Tuberculose, Vaccinatie